Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2007 by Maimonides Medical Center.
Recruitment status was  Recruiting
Information provided by:
Maimonides Medical Center
ClinicalTrials.gov Identifier:
First received: November 20, 2007
Last updated: November 21, 2007
Last verified: September 2007
The proposed prospective study aims to determine whether interpretation of PSA levels in morbidly obese men require correction due to the obesity itself. If PSA levels are found to rise after weight loss, interpretation of PSA levels in morbidly obese men may be improved by upward correction of the PSA level. A 'correction factor' may be proposed for the interpretation of PSA levels in obese men, toward the clinical decision regarding indication for prostate biopsy.

Condition Intervention
Prostate Cancer
Procedure: Bariatric Surgery

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Effect of Lap-Band Induced Weight Loss on Serum PSA Levels, Testosterone, Estrogen and Other Serum Markers

Resource links provided by NLM:

Further study details as provided by Maimonides Medical Center:

Primary Outcome Measures:
  • PSA value [ Time Frame: 18 months ]

Secondary Outcome Measures:
  • quality of life, testosterone, esradiol, leptin, HbA1c, cholesterol, prostate volume [ Time Frame: 18 months ]

Biospecimen Retention:   Samples Without DNA
blood samples

Estimated Enrollment: 20
Study Start Date: November 2007
Estimated Study Completion Date: December 2009
Groups/Cohorts Assigned Interventions
1 Procedure: Bariatric Surgery
one time lapb-band gastric bypass surgery

Detailed Description:
The main objective of this study is to determine whether interpretation of PSA levels in morbidly obese men require correction due to the obesity itself. Secondary outcome measures that will be followed include the affect of obesity and weight loss on testosterone, estradiol and leptin. In as much as these might also affect PSA, we will be measuring these values as well. Also, we do not know the effects of lap-band induced weight loss on clinical outcome measures of sexual, bowel and urinary function. Thus we will aim to investigate these parameters as well.

Ages Eligible for Study:   20 Years to 60 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients asked to enroll will be obese men who are undergoing bariatric surgery, lap-band surgery, at Maimonides Medical Center.

Inclusion Criteria:

  • obese men undergoing lap-band surgey

Exclusion Criteria:

  • prior diagnosis of prostate cancer, prior prostate surgery, use of 5-alpha reductase inhibitors and history prostatitsis or recurrent UTI.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00562341

United States, New York
Maimonides Medical Center Recruiting
Brooklyn, New York, United States, 11219
Contact: Jason Wynberg       jwynberg@maimonidesmed.org   
Principal Investigator: Jason Wynberg, MD         
Sub-Investigator: Danny Sherwinter, MD         
Sub-Investigator: Richard Savel, MD         
Sub-Investigator: Payam Hakimian, MD         
Sub-Investigator: Michael l Blute, Jr, MD         
Sub-Investigator: James A Kashanian, MD         
Sponsors and Collaborators
Maimonides Medical Center
Principal Investigator: Jason Wynberg, MD MMC
  More Information

ClinicalTrials.gov Identifier: NCT00562341     History of Changes
Other Study ID Numbers: 07/09/VA18 
Study First Received: November 20, 2007
Last Updated: November 21, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Maimonides Medical Center:
prostate cancer

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms

ClinicalTrials.gov processed this record on May 26, 2016